ArriVent BioPharma, Inc. (AVBP) Operating income 2023–2025
ArriVent BioPharma, Inc. (AVBP) annual operating income history from SEC filings — each fiscal year as reported.
-$177.5MFY2025 · since FY2023: -$74.6M → -$177.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$177.5M | -88.2% |
| FY2024 | -$94.3M | -26.4% |
| FY2023 | -$74.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice